$ Value
$0
Shares
9,104
Price
$0
Filed
Dec 11
Insider
Name
Cross Shawn
Title
Chief Financial Officer
CIK
0001734779
Roles
Transaction Details
Transaction Date
2025-12-10
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
175,000
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.30, inclusive. | The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Filing Info
Cross Shawn's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-22 | PCRX | M | $25K |
| 2026-04-22 | PCRX | ▼ | $38K |
| 2026-04-22 | PCRX | M | $0 |
| 2026-04-21 | PCRX | M | $47K |
| 2026-04-21 | PCRX | ▼ | $71K |
| 2026-04-21 | PCRX | M | $0 |
| 2026-04-20 | PCRX | M | $127K |
| 2026-04-20 | PCRX | ▼ | $194K |
| 2026-04-20 | PCRX | M | $0 |
| 2026-02-11 | PCRX | A | $0 |
Other Insiders at PCRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILLIAMS KRISTEN
Chief Administrative Officer
|
— | $270K | 2026-02-11 |
|
RIKER LAUREN
Senior Vice President, Finance
|
— | $83K | 2026-02-11 |
| Kronenfeld Mark A. | — | — | 2025-06-11 |
| Froimson Mark | — | $11K | 2026-03-17 |
|
Cross Shawn
Chief Financial Officer
|
— | $303K | 2026-04-22 |
| Hirawat Samit | — | — | 2026-01-27 |
|
Lee Frank D.
Chief Executive Officer
|
— | — | 2026-02-11 |
|
SLONIN JONATHAN
Chief Medical Officer
|
— | $74K | 2026-03-17 |
|
Teehan Brendan
Chief Commercial Officer
|
— | — | 2026-02-11 |